Financhill
Sell
48

BBIO Quote, Financials, Valuation and Earnings

Last price:
$76.56
Seasonality move :
-6.92%
Day range:
$76.38 - $77.32
52-week range:
$27.23 - $78.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
41.22x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
2M
1-year change:
168.24%
Market cap:
$14.8B
Revenue:
$221.9M
EPS (TTM):
-$4.19

Earnings Data

Next earnings date for BBIO
Feb 19
2026
Most recent earnings per share
-$0.95
Missed by $0.18
(Oct 29/2025)
Consensus Estimate
-$0.78
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BBIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/19/2026 Q4 $148.1M -- -- -$0.62 --
10/29/2025 Q3 $106.1M $120.7M -$0.95 -$0.78 -$0.18
08/05/2025 Q2 $88.8M $110.6M -$0.95 -$0.61 -$0.35
04/29/2025 Q1 $57.7M $116.6M -$0.88 -$1.00 $0.12
02/20/2025 Q4 $4M $5.9M -$1.40 -$1.09 -$0.31
11/12/2024 Q3 $3.4M $2.7M -$0.86 -$0.86 $0.00
08/01/2024 Q2 $4.5M $2.2M -$0.39 -$0.94 $0.55
05/02/2024 Q1 $83.8M $211.1M -$0.20 -$0.54 $0.35
02/22/2024 Q4 $3.8M $1.7M -$0.96 -$0.80 -$0.17
11/02/2023 Q3 -- $4.1M -$1.08 -- --
08/03/2023 Q2 -- $1.6M -$0.98 -- --
05/04/2023 Q1 -- $1.8M -$0.92 -- --
02/23/2023 Q4 -- $1.9M -$0.92 -- --
11/03/2022 Q3 -- $338K -$0.93 -- --
08/04/2022 Q2 -- $73.7M -$0.07 -- --
05/05/2022 Q1 -- $1.7M -$1.35 -- --
02/24/2022 Q4 -- $12.9M -$1.01 -- --
11/04/2021 Q3 -- $2.3M -$1.06 -- --
08/05/2021 Q2 -- $54M -$0.66 -- --
05/06/2021 Q1 -- $462K -$1.18 -- --
02/25/2021 Q4 -- $122K -$1.01 -- --
11/05/2020 Q3 -- $8.1M -$0.98 -- --
08/11/2020 Q2 -- -- -$1.03 -- --
05/13/2020 Q1 -- -- -$0.78 -- --
03/02/2020 Q4 -- $13.8M -$0.62 -- --
11/07/2019 Q3 -- $26.7M -$0.51 -- --
08/14/2019 Q2 -- -- -$0.71 -- --
03/31/2019 Q1 -- -- -$0.50 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
09/30/2018 Q3 -- -- -$0.52 -- --
06/30/2018 Q2 -- -- -$0.26 -- --
03/31/2018 Q1 -- -- -$0.30 -- --

BridgeBio Pharma, Inc. Earnings Questions

  • How Much did BridgeBio Pharma, Inc. Generate in Revenue Last Quarter?

    BridgeBio Pharma, Inc. reported $120.7M worth of top line sales in its most recent quarter.

  • Did BridgeBio Pharma, Inc. Beat Earnings Last Quarter?

    BridgeBio Pharma, Inc. announced earnings per share of -$0.95 which represents a miss of analyst forecast a -$0.78 per share.

  • Is BridgeBio Pharma, Inc. Profitable?

    BridgeBio Pharma, Inc. reported $113.4M that represents $0.59 per share over the last quarter.

  • What is the Analyst Consensus for BridgeBio Pharma, Inc. EPS Next Year?

    BridgeBio Pharma, Inc.'s earnings are forecast to decrease from -$2.88 per share to -$2.39 per share next year representing a decrease of -10.79%.

  • When is BridgeBio Pharma, Inc.'s Earnings Date?

    BridgeBio Pharma, Inc.'s next earnings date is February 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock